Effect of the oxidation state of LDL on the modulation of arterial vasomotor response in vitro

Atherosclerosis

Volumn 133, Issue 2, 1997, Pages 183-192

  Mougenot, Nathalie ^a   Lesnik, Philippe ^a   Ramirez Gil, Juan Fernando ^a   Nataf, Patrick ^a   Diczfalusy, Ulf ^b   Chapman, M John ^a   Lechat, Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Copper oxidized low density lipoprotein; Endothelium dependent relaxation; Human internal mammary artery; Oxysterol; Rat thoracic aorta; Vasoconstriction

Indexed keywords

ACETYLCHOLINE; COPPER; LOW DENSITY LIPOPROTEIN; NORADRENALIN; STEROL DERIVATIVE;

ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD VESSEL TONE; DEPOLARIZATION; ELECTRICITY; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASCULAR RING; VASOCONSTRICTION; VASOMOTOR REFLEX;

EID: 0030822504     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00124-X     Document Type: Article

References (57)

1. Steinberg D.S., Parthasarathy S., Carew T.E., Khoo J.D., Witztum J.L. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med. 320:1989;915.
2. Carpenter K.L.H., Taylor S.E., Ballantine J.A., Fussel B., Hallivell B., Mitchinson M.J. Lipids and oxidised lipids in human atheroma and normal aorta. Biochem Biophys Acta. 1167:1993;121.
3. Dzeletovic S., Babiker A., Lund E., Diczfalusy U. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein. Chem Phys Lipids. 78:1995;119.
4. Esterbauer H., Dieber-Rotheneder M., Waeg G., Striegl G., Jurgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol. 3:1990;77.
5. Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis. 98:1993;1.
6. Cazzolato G., Avogaro P., Bittolo-Bon G. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic Biol Med. 11:1991;247.
7. Hodis H.N., Kramsch D.M., Avogaro P.et al. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein. J Lipid Res. 35:1994;669.
8. Zeiher A.M., Schachinger V. Coronary endothelial vasodilatator dysfunction: clinical relevance and therapeutic implications. Z Kardiol. 83:1994;7.
9. Kalsner S. Coronary artery spasm: multiple causes and multiple roles in heart disease. Biochem Pharmacol. 49:1995;859.
10. Borsum T. Biochemical properties of vascular endothelial cells. Virchows Archiv Cell Pathol. 60:1991;279.
11. Cox D.A., Cohen M.L. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis. Pharmacol Rev. 48:1996;3.
12. Flavahan N.A. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction of EDRF/nitric oxide activity. Circulation. 85:1992;1927.
13. Boulanger C.M., Tanner F.C., Bea M.L., Hann A.W.A., Werner A., Luscher T.F. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res. 70:1992;1191.
14. Jougasaki M., Kugiyama K., Saito Y., Nakao K., Imura H., Yasue H. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells. Circ Res. 71:1992;614.
15. Thorin E., Hamilton C.A., Dominiczak M.H., Reid J.L. Chronic exposure of cultured bovine endothelial cells to oxidized LDL abolishes prostacyclin release. Arterioscler Thromb. 14:1994;453.
16. Galle J., Mulsch A., Busse R., Bassenge E. Effects of native and oxidized LDL on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb. 11:1991;198.
17. Casino P.R., Kilcoyne C.M., Quyyumi A.A., Hoeg J.M., Panza J.A. The role of nitric oxide in endothelium-dependent vasodilatation of hypercholesterolemic patients. Circulation. 88:1993;2541.
18. Liao L.X., Shin W.S., Lee W.Y., Clark S.L. Oxidized LDL decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 270:1995;319.
19. Plane F., Bruckdorfer K.R., Kerr P., Steur A., Jacobs M. Oxidative modificaton of low-density lipoproteins and the inhibition of relaxation mediated by endothelium-derived nitric oxide in rabbit aorta. Br J Pharmacol. 38:1992;216.
20. Galle J., Banersachs J., Busse R., Bassenge E. Inhibition of cyclic AMP and cyclic GMP-mediated dilatations in isolated arteries by oxidised LDL. Effect of native and oxidized LDL on formation of endothelium-derived relaxing factor. Arterioscler Thromb. 12:1992;180.
21. Gleason M., Medow M., Tulenko T. Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. Circ Res. 69:1991;216.
22. Galle J., Bassenge E., Busse R. Oxidized LDL potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res. 66:1990;1287.
23. Murohara T., Kugiyama K., Ohgushi M., Sugiyama S., Ohta Y., Yasue H. LPC in oxidized LDL elicits vasoconstraction and inhibits endothelium-dependent relaxation. Am J Physiol. 267:1994;H2441.
24. Simon B.C., Cunningham L.C., Cohen R.A. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 86:1990;75.
25. Niu X.L., Liu L.Y., Hu M.L., Chen X. Some similarities in vascular effects of oleil acid and oxidized low density lipoproteins on rabbit aorta. J Mol Cell Cardiol. 27:1995;531.
26. Maggi E., Manzini S., Evangelista S., Meli A. High-cholesterol diet induces altered responsiveness of rabbit arterial smooth muscle to noradrenaline. Pharmacology. 30:1985;273.
27. Verbeuren T.J., Jordaens F.H., Zonnekeyn L.L., Van Hove C.E., Coene M.C., Herman A.G. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res. 58:1986;552.
28. Heistad D., Armstrong M., Marcus M., Piegors D., Mark K. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res. 54:1984;711.
29. Ginsburg R., Bristow M., Davies K., Dibiase A., Billingham M. Quantitative pharmacologic response of normal and atherosclerotic isolated human epicardial coronary arteries. Circulation. 69:1984;430.
30. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 344:1990;160.
31. Mangin E.L., Kugiyama K., Nguy J.H., Kerns S.A., Henry P.D. Effects of lysolipids and oxidatively modified low-density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res. 72:1993;161.
32. Yokoyama M., Hirata K., Miyake R., Akita H., Ishikawa Y., Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 168:1990;301.
33. Tanner F.C., Noll G., Boulanger C.M., Luscher T.F. Oxidized low density lipoproteins inhibits relaxations of porcine coronary artery: role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 83:1991;2012.
34. Hayashi T., Ishikawa T., Kuzuya M.et al. Chelation of copper reduces inhibition by oxidized low density lipoprotein of endothelium-dependent relaxation in porcine coronary arteries. Heart Vessels. 9:1994;283.
35. Plane F., Kerr P., Bruckdorfer K.R., Jacobs M. Inhibition of endothelium-dependent relaxation by oxidized low density lipoproteins. Biochem Soc Trans. 18:1990;1177.
36. Chapman M.J., Laplaud P.M., Luc G.et al. Further resolution of the low-density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res. 29:1988;442.
37. El Saadani M.H., Esterbauser H., El Sayed M., Goher M., Nassar A.Y., Jurgens G. A spectrophotometric assay for lipid peroxides in the serum lipoproteins using a commercially available reagents. J Lipid Res. 30:1989;627.
38. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265.
39. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radic Res Commun. 6:1989;67.
40. Lesnik P., Dentan D., Vonica A., Moreau M., Chapman M.J. Tissue factor pathway inhibitor associated with LDL is inativated by cell- and copper-mediated oxidation. Arterioscler Thromb Vasc Biol. 15:1995;1121.
41. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1976;302.
42. Basu S.K., Goldstein J.L., Anderson R.G.W., Brown M.S. Degradation of cationized low-density lipoprotein and regulation of cholesterol metabolism in homosygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA. 73:1976;3178.
43. Noble R.P. Electrophoretic separation of plasma lipoproteins in agarose-gel. J Lipid Res. 9:1968;693.
44. Sachinidis A, Locher R, Mengden T, Steiner A, Vetter W. Vasoconstriction: a novel activity for low-density lipoprotein. Biochem Biophys Res Commun (1989) 315.
45. Yokoyama M., Henry P. Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterol. Circ Res. 45:1979;479.
46. Peng S.K., Tham P., Taylor C.B., Mikkelson B. Cytotoxicity of oxidation derivatives of cholesterol on cultered aortic smooth muscle cells and their effect on cholesterol biosynthesis. Am J Clin Nutr. 32:1979;1033.
47. Hughes H., Mathews B., Lenz M.L., Guyton J.R. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler Thromb. 14:1994;1177.
48. Zhou Q., Smith T.L., Kummerow F.A. Cytotoxicity of oxysterols on cultered smooth muscle cells from human umbilical arteries. Proc Soc Exp Biol Med. 202:1994;75.
49. Esterbauser H. Cytotoxicity and genotoxicity of lipid oxidation products. Am J Clin Nutr. 57:1991;423.
50. Pettersen K.S., Boberg K.M., Stabursvik A., Pryds H. Toxicity of oxygenated cholesterol derivatives toward cultered human umbilical vein endothelial cells. Arterioscler Thromb. 11:1991;423.
51. Sevanian A., Berliner J., Peterson H. Uptake, metabolism and cytotoxicity of isomeric cholesterol-5,6 epoxides in rabbit aortic endothelial cells. J Lipid Res. 32:1991;147.
52. Björkhem I., Anderson O., Diczfalusy U.et al. Atherosclerosis and steril 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci USA. 91:1994;8592.
53. Takahashi M., Yui Y., Yasumoto H.et al. Lipoproteins are inhibitors of endothelium-dependent relaxation of rabbit aorta. Am J Physiol. 258:1990;1.
54. Andrews H.E., Bruckdorfer K.R., Dunn R.C., Jacobs M. Low density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 327:1987;237.
55. Deckert V, Persegol L, Viens L et al. Inhibitors of arterial relaxation among components of human oxidized low density lipoproteins. Cholesterol derivatives oxidized in position 7 are potent inhibitors of the endothelium-dependent relaxation. Circulation 1997;95:723.
56. Sparrow C.P., Parthasarathy S., Steinberg D. A macrophage receptor that recognised oxidezes LDL but not acetylated LDL. J Bio Chem. 264:1989;2599.
57. Verdière C., Drobinski G., Lechat P., Mezghani M., Grosgrogeat Y. Effets de la trinitrine injectable sur les sténoses coronaires athéromateuses. Arch Mal Coeur. 6:1985;853.